3 (0, 1%); HR 0, 17 (CI 0, 05; 0, 57)) og risikoen for østrogenreceptor- positiv mammacancer med 81% (placebo:
3 (0.1%); HR 0.17 (CI 0.05, 0.57)) and the risk of estrogen receptor (ER) positive breast cancer by 81% (placebo: